Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» Therachon
Therachon
Why dwarfism start-up Therachon picked Pfizer takeout over IPO
Why dwarfism start-up Therachon picked Pfizer takeout over IPO
BioCentury
Pfizer
Therachon
IPOs
Flag link:
Pfizer agrees on $340M upfront to buy Therachon for dwarfism drug
Pfizer agrees on $340M upfront to buy Therachon for dwarfism drug
Fierce Biotech
Pfizer
Therachon
short-limbed dwarfism
M&A
Flag link:
